儿童SARS-CoV-2感染:临床表现、传染性与免疫应答
该研究纳入192名0-22岁儿童,其中26%确诊急性SARS-CoV-2感染,9%符合MIS-C标准。急性感染儿童中仅51%有发热,症状非特异;症状出现头2天鼻咽病毒载量最高,显著高于重症住院成人(P=.002)。年轻儿童ACE2表达较低(P=.004),重症MIS-C中IgM/IgG升高(P<.001)并见体液免疫失调。
要点
- 儿童急性SARS-CoV-2感染常无发热或症状非特异,但仍可能传播病毒。
- 症状早期鼻咽病毒载量高,可高于重症住院成人。
- 重症MIS-C与针对刺突蛋白受体结合域的IgM/IgG升高及体液免疫失调相关。
核心结论
- 儿童可能是SARS-CoV-2大流行中的潜在传染源,尽管疾病较轻或无症状。
- 免疫失调与严重的感染后MIS-C相关。
研究设计与样本
- 研究纳入0-22岁疑似SARS-CoV-2感染、确诊/疑似感染或MIS-C的儿童,来自急诊或住院,入组马萨诸塞州总医院儿童COVID-19生物样本库。
- 采集鼻咽、口咽和/或血液标本,定量SARS-CoV-2病毒载量、ACE2 RNA水平及SARS-CoV-2血清学。
主要发现
- 急性SARS-CoV-2感染儿童中仅25名(51%)有发热,症状非特异。
- 症状出现头2天鼻咽病毒载量最高,显著高于重症住院成人(P=.002)。
- 年龄不影响病毒载量,但年轻儿童ACE2表达较低(P=.004)。
- 重症MIS-C中针对SARS-CoV-2刺突蛋白受体结合域的IgM和IgG升高(P<.001),并见体液免疫失调。
关键数值与推荐
- MIS-C标准:18/192(9%)。
- 鼻咽病毒载量比较:症状头2天儿童 vs 重症住院成人,P=.002。
- ACE2表达与年龄比较:年轻儿童较低,P=.004。
临床怎么用
- 儿科医生应认识到儿童SARS-CoV-2感染可能无发热或症状非特异,需结合流行病学和检测判断。
- 儿童症状早期病毒载量高,提示传染性可能较强,应加强早期防护和隔离措施。
- 对重症MIS-C患儿,应关注体液免疫失调,IgM/IgG升高可能辅助诊断。
局限性
- 单中心研究,样本量有限,结果外推需谨慎。
- 未报告儿童与成人病毒载量比较的具体数值和置信区间。
- 未报告免疫应答动态变化的具体数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: As schools plan for re-opening, understanding the potential role children play in the coronavirus infectious disease 2019 (COVID-19) pandemic and the factors that drive severe illness in children is critical. STUDY DESIGN: Children ages 0-22 years with suspected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection presenting to urgent care clinics or being hospitalized for confirmed/suspected SARS-CoV-2 infection or multisystem inflammatory syndrome in children (MIS-C) at Massachusetts General Hospital were offered enrollment in the Massachusetts General Hospital Pediatric COVID-19 Biorepository. Enrolled children provided nasopharyngeal, oropharyngeal, and/or blood specimens. SARS-CoV-2 viral load, ACE2 RNA levels, and serology for SARS-CoV-2 were quantified. RESULTS: A total of 192 children (mean age, 10.2 ± 7.0 years) were enrolled. Forty-nine children (26%) were diagnosed with acute SARS-CoV-2 infection; an additional 18 children (9%) met the criteria for MIS-C. Only 25 children (51%) with acute SARS-CoV-2 infection presented with fever; symptoms of SARS-CoV-2 infection, if present, were nonspecific. Nasopharyngeal viral load was highest in children in the first 2 days of symptoms, significantly higher than hospitalized adults with severe disease (P = .002). Age did not impact viral load, but younger children had lower angiotensin-converting enzyme 2 expression (P = .004). Immunoglobulin M (IgM) and Immunoglobulin G (IgG) to the receptor binding domain of the SARS-CoV-2 spike protein were increased in severe MIS-C (P < .001), with dysregulated humoral responses observed. CONCLUSIONS: This study reveals that children may be a potential source of contagion in the SARS-CoV-2 pandemic despite having milder disease or a lack of symptoms; immune dysregulation is implicated in severe postinfectious MIS-C.
引用
- Yonker LM, Neilan AM, Bartsch Y, et al. Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses. J Pediatr. 2020. PMID: 32827525. doi:10.1016/j.jpeds.2020.08.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。